Abstract:Background Development of new drugs is a time-consuming and costly process, and the cost is still increasing in recent years. However, the number of drugs approved by FDA every year per dollar spent on development is declining. Drug repositioning, which aims to find new use of existing drugs, attracts attention of pharmaceutical researchers due to its high efficiency. A variety of computational methods for drug repositioning have been proposed based on machine learning approaches, network-based approaches, matrix decomposition approaches, etc. Results We propose a novel computational method for drug repositioning. We construct and decompose three-dimensional tensors, which consist of the associations among drugs, targets and diseases, to derive latent factors reflecting the functional patterns of the three kinds of entities. The proposed method outperforms several baseline methods in recovering missing associations. Most of the top predictions are validated by literature search and computational docking. Latent factors are used to cluster the drugs, targets and diseases into functional groups. Topological Data Analysis (TDA) is applied to investigate the properties of the clusters. We find that the latent factors are able to capture the functional patterns and underlying molecular mechanisms of drugs, targets and diseases. In addition, we focus on repurposing drugs for cancer and discover not only new therapeutic use but also adverse effects of the drugs. In the in-depth study of associations among the clusters of drugs, targets and cancer subtypes, we find there exist strong associations between particular clusters. Conclusions The proposed method is able to recover missing associations, discover new predictions and uncover functional clusters of drugs, targets and diseases. The clustering of drugs, targets and diseases, as well as the associations among the clusters, provides a new guiding framework for drug repositioning.

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

Drug repositioning based on heterogeneous networks and variational graph autoencoders

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

SiSGC: A Drug Repositioning Prediction Model Based on Heterogeneous Simplifying Graph Convolution.

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Drug repositioning with adaptive graph convolutional networks

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

Drug repositioning based on weighted local information augmented graph neural network

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

Semi-supervised Graph Cut Algorithm for Drug Repositioning by Integrating Drug, Disease and Genomic Associations.

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

deepDR: a network-based deep learning approach to in silico drug repositioning

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm